Anti-Kp antibody: Getting to know a strange and dangerous specificity

Anti-Kp<sup>a</sup> is an irregular antibody of clinical significance directed against the red blood cell antigen Kp<sup>a</sup> of the Kell system. It is rare in the general population and, therefore, uncommon as a cause of transfusion or hemolytic complications. It has been documented in isolated cases, mainly in the context of alloimmunization after transfusion exposure or during pregnancy; its incidence in clinical practice is limited and can be difficult to detect in routine pre-transfusion testing, which could lead to failure to identify the antibody prior to transfusion. The production of Anti-Kp<sup>a</sup> antibodies is less common than antibodies against other Kell system antigens, such as anti-K. However, when generated, these antibodies can mediate hemolytic reactions in patients receiving incompatible blood and can cause hemolytic disease in the fetus since in addition to immune destruction of red blood cells, Kell system antibodies such as Anti-Kp<sup>a</sup> can cause suppression of fetal erythropoiesis, resulting in severe anemia.

Authors

Institutions

Publication Details

Journal
Hematology Transfusion and Cell Therapy
Published
2026-03-12
DOI
https://doi.org/10.1016/j.htct.2026.106269
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-Kp antibody: Getting to know a strange and dangerous specificity

Marcela QUINTERO SANTACRUZ
Hematology Transfusion and Cell Therapy
Blood groups and transfusion
article

Anti-Kp antibody: Getting to know a strange and dangerous specificity

Marcela QUINTERO SANTACRUZ
article en

Abstract

Anti-Kp<sup>a</sup> is an irregular antibody of clinical significance directed against the red blood cell antigen Kp<sup>a</sup> of the Kell system. It is rare in the general population and, therefore, uncommon as a cause of transfusion or hemolytic complications. It has been documented in isolated cases, mainly in the context of alloimmunization after transfusion exposure or during pregnancy; its incidence in clinical practice is limited and can be difficult to detect in routine pre-transfusion testing, which could lead to failure to identify the antibody prior to transfusion. The production of Anti-Kp<sup>a</sup> antibodies is less common than antibodies against other Kell system antigens, such as anti-K. However, when generated, these antibodies can mediate hemolytic reactions in patients receiving incompatible blood and can cause hemolytic disease in the fetus since in addition to immune destruction of red blood cells, Kell system antibodies such as Anti-Kp<sup>a</sup> can cause suppression of fetal erythropoiesis, resulting in severe anemia.

Hematology Transfusion and Cell TherapyVol. 48(2)
Universidad del Valle (CO)
Good health and well-being
Openalex Percentile: Top 23%
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.